本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioNexus Gene Lab Corp.

1.33
-0.0596-4.29%
成交量:8,176
成交额:1.05万
市值:390.14万
市盈率:-1.07
高:1.33
开:1.33
低:1.22
收:1.39
52周最高:5.89
52周最低:1.07
股本:293.34万
流通股本:188.10万
量比:0.73
换手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-1.2467
每股收益(LYR):-1.6075
净资产收益率:-33.66%
总资产收益率:-18.99%
市净率:0.50
市盈率(LYR):-0.83

数据加载中...

2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/05

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/31

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/31

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/05/31

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/31

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/05/31

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/05/24

SEC问询函

Form CORRESP - Correspondence
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/18

重要事件披露

Form 8-K - Current report
2024/04/16

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/26

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/01/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/17

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/20

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/31

重要事件披露

Form 8-K/A - Current report: [Amend]